Literature DB >> 20735467

Uncertainty, lack of control and emotional functioning in women with metastatic breast cancer: a review and secondary analysis of the literature using the critical appraisal technique.

M Warren1.   

Abstract

A diagnosis of metastatic (or secondary) breast cancer is frequently more distressing than the diagnosis of a primary tumour since it indicates that the cancer is no longer curable. Relatively little is known, however, about women's experiences of this condition in comparison with those diagnosed with primary breast cancer. This paper therefore reports findings from a secondary analysis of the published literature on the topic using tools from the critical appraisal skills programme to identify and analyse appropriate papers, and the constant comparative method as a means of identifying any overarching or dominant themes emerging from the literature. Uncertainty, lack of control and poor emotional functioning emerged as the main themes affecting women with metastatic breast cancer. These are discussed in relation to their antecedents in the original studies and their implications for nursing care. The themes demonstrate that living with metastatic (or secondary) breast cancer is a multifaceted experience that is influenced by a large number of factors, many of which are under-researched in comparison with those affecting women diagnosed with primary disease. It is clear, however, that women affected by the condition need a great deal more support than they currently receive, and new services may be required to meet these needs.

Entities:  

Mesh:

Year:  2010        PMID: 20735467     DOI: 10.1111/j.1365-2354.2010.01215.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

Review 1.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

2.  Support for Young Adult Cancer Patients: Perspectives of Patients and their Mothers.

Authors:  Nathanael B Stanley; Gwendolyn Quinn; Damon Reed; Andrew Galligan; Maija Reblin
Journal:  J Cancer Educ       Date:  2019-12       Impact factor: 2.037

3.  Low social and family well-being is associated with greater RAGE ligand s100A8/A9 and interleukin-1 beta levels in metastatic breast cancer patients.

Authors:  Joaquim C Reis; Luzia Travado; Elsa Seixas; Berta Sousa; Michael H Antoni
Journal:  Brain Behav Immun Health       Date:  2022-02-22

4.  Potential inequities in availability of care from breast care nurses: a qualitative study reporting the experiences and perspectives of women with metastatic breast cancer in Australia.

Authors:  Andrea L Smith; Frances Boyle; Sophie Lewis
Journal:  BMC Health Serv Res       Date:  2022-07-22       Impact factor: 2.908

5.  Mentalization and Its Relation to Life Satisfaction and the Level of Mental Adjustment to Illness in Women with Breast Cancer-A Pilot Study.

Authors:  Mariusz Cieślak; Joanna Kozaka; Paulina Beata Golińska; Mariola Bidzan
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

6.  Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.

Authors:  N Harbeck; S Iyer; N Turner; M Cristofanilli; J Ro; F André; S Loi; S Verma; H Iwata; H Bhattacharyya; K Puyana Theall; C H Bartlett; S Loibl
Journal:  Ann Oncol       Date:  2016-03-30       Impact factor: 32.976

7.  Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.

Authors:  V Bjelic-Radisic; F Fitzal; M Knauer; G Steger; D Egle; R Greil; P Schrenk; M Balic; Ch Singer; R Exner; L Soelkner; Michael Gnant
Journal:  BMC Cancer       Date:  2020-05-06       Impact factor: 4.430

8.  A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.

Authors:  Laura B Oswald; Brandy Arredondo; Mika Kadono; Dinorah Martinez-Tyson; Cathy D Meade; Frank Penedo; Michael H Antoni; Hatem Soliman; Ricardo L B Costa; Heather S L Jim
Journal:  Cancer Med       Date:  2021-06-24       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.